Skip to main content
FutureCore Co.,Ltd. logo

FutureCore Co.,Ltd. — Investor Relations & Filings

Ticker · 151910 ISIN · KR7151910007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2023-09-26 M&A Activity
Country KR South Korea
Listing KO 151910

About FutureCore Co.,Ltd.

http://futurecore.co.kr/en/home-e/

FutureCore Co., Ltd. is a company that develops, manufactures, and sells electrical and electronic components. The company specializes in the production of optical filters for imaging applications, particularly for phone and camera modules. Its main products include a variety of optical filters such as IR cutoff filters, blue filters, IR pass filters, and IR band filters. In addition to its filter products, the company also manufactures Hall sensors.

Recent filings

Filing Released Lang Actions
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 1% confidence The document is a regulatory filing from SBW Life Science regarding an amendment (correction) to a previous announcement about the acquisition of shares in another company (Nanos Biotech Inc.). It details changes to the expected acquisition date and provides updated financial summaries of the target company. This type of filing, which reports on corporate investment activities and M&A-related disclosures, falls under the category of M&A Activity (TAR) as it pertains to the acquisition of another entity's shares.
2023-09-26 Korean
전환가액의조정(제6회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (SBW Life Science) regarding the adjustment of the conversion price for convertible bonds (6th series). This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under 'Capital/Financing Update' as it directly relates to the company's financing activities and capital structure adjustments.
2023-09-18 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity Classification · 1% confidence The document is a regulatory filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) regarding a 'Decision to Transfer Shares and Equity Securities of Other Corporations' (타법인 주식 및 출자증권 양도결정). It details a correction (정정신고) to a previously filed report concerning the payment schedule for a share transfer. Since this is a specific regulatory disclosure regarding corporate asset transactions and M&A-related activity (divestiture), and it does not fit into the specific categories of M&A (TAR) which usually refers to takeover bids or mergers, nor is it a simple announcement, it falls under the general regulatory filing category for material corporate events.
2023-08-30 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for SBW Life Sciences, covering the period from 2023.01.01 to 2023.06.30. It contains detailed corporate information, business descriptions, and governance details, which is characteristic of an interim financial report. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
전환가액의조정(제5회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from SBW Life Science regarding the adjustment of the conversion price for its 5th series convertible bonds. It details the change in conversion price, the number of convertible shares, the reason for the adjustment (market price decline), and the calculation methodology. This type of disclosure regarding capital structure and debt-to-equity conversion terms falls under 'Capital/Financing Update'.
2023-08-07 Korean
타인에대한담보제공결정(2021년)
Capital/Financing Update Classification · 1% confidence The document is a regulatory disclosure regarding a 'Decision to Provide Collateral to Others' (타인에 대한 담보제공 결정) filed by SBW Life Science. This type of disclosure, which details financial guarantees or collateral provided by a company for its subsidiaries or third parties, does not fit into specific categories like earnings releases, annual reports, or director dealings. Under the provided definitions, such miscellaneous regulatory disclosures are best classified as 'Regulatory Filings' (RNS).
2023-07-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.